17.11

Opening statements + Dr.Gur H. Key note lecture -Microbiota modulates antitumoral immunity

 

Prof. Wolf I. - Key note lecture - Cachexia in GI cancers

 

Prof. Aderka D. - Satellite Merck: The future is here: personalized medicine which can't distinguish between its right and left (colon)

 

Dr. Geva R. - Treatment option of refractory metastatic colorectal patient

 

 

Dr. Beni A. - Examining the role for resecting the primary in mCRC

 

Prof. Sabo E. - Innovative pathological parameters in colon cancer from polyp to tumor

 

Dr. Shulman K. - The silent masses - immunotherapy in MSS MCRC

 

Dr. Meirovich A. - The role of radiotherapy in the mCRC setting

 

18.11

Dr. Kori I. - Local therapies in HCC how to choose between them?

Dr. Purim O. - Systemic therapies options in advanced HCC

 

Dr.Pelles S. - Who should treat HCC? Hepatologists or Oncologists

 

Dr. Brenner R. - Diagnosis of HCC, the role of imaging vs biopsy

Dr.Hubert A. - Satellite BMS: Immunotherapy in gastrointestinal cancer: Latest results, current studies and future perspectives

Dr.Ben Aharon I. - Update on hot topics from ASCO and ESMO

 

Prof. Grothey A. - "second line treatment options in HER-2 positive and HER-2 negative gastric cancer”?"

 

Prof. Brenner B. - Two decades of clinical trials with targeted therapy in Gastric cancer - Where are we now?

 

Dr.Yarom N.  - Is there still a role for radiotherapy in Gastric cancer?

 

Dr. Man S. - Can we personalize chemotherapy for gastric cancer?

 

Dr.Shacham Shmueli E. - Satellite Lilly: Exploring the anti angiogenic treatment in gastric cancer

 

נושאים קשורים:  כנסים